Other diseases of inner ear
Chapter 8:Diseases of the ear and mastoid process
ICD-10 H83 is a billable code used to indicate a diagnosis of other diseases of inner ear.
The ICD-10 code H83 encompasses a variety of diseases affecting the inner ear, which can lead to significant auditory and vestibular dysfunction. Conditions classified under this code may include labyrinthitis, Meniere's disease, and other unspecified inner ear disorders. Clinical presentations often involve symptoms such as vertigo, tinnitus, hearing loss, and balance disturbances. Diagnostic criteria typically include audiometric testing, imaging studies like MRI or CT scans, and clinical evaluations to rule out other causes of ear-related symptoms. Management strategies may vary from pharmacological interventions, such as diuretics for Meniere's disease, to surgical options like vestibular nerve section or labyrinthectomy in severe cases. Accurate coding is essential for proper reimbursement and to reflect the complexity of the patient's condition, as well as to ensure appropriate treatment pathways are followed.
Detailed history of symptoms, audiometric test results, and imaging studies.
Patients presenting with vertigo, hearing loss, or tinnitus.
Ensure all relevant diagnostic tests are documented to support the diagnosis.
Neurological examination findings, imaging results, and differential diagnoses.
Patients with vestibular disorders presenting with balance issues.
Document any neurological assessments performed to differentiate from other conditions.
Used when evaluating a patient with suspected inner ear disease.
Document the results of the audiometric evaluation and any relevant history.
Otolaryngologists should ensure that all findings are clearly documented.
H83 includes various inner ear disorders such as labyrinthitis, Meniere's disease, and other unspecified diseases affecting the inner ear.
H83 is used for inner ear disorders, while H60 codes pertain to outer ear conditions. Proper documentation of the site of the disorder is crucial.